Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
 Disease Category: Prostate Cancer
Location: United States, FL

Trial Information

Metastatic, Androgen-Independent study for patients with Prostate Cancer

Phase II study to assess safely, efficacy and tolerability of three doses of a study medication in patients with Metastatic, Androgen-Independent Prostate Cancer

Patient Inclusion Criteria:

  • Males at least 18 years and older
  • Must have confirmed prostate adenocarcinoma with metastatic, progressive disease while on androgen deprivation therapy
  • PSA ≥ 5ng/ml

Patient Exclusion Criteria:

  • Prior chemotherapy for prostate cancer
  • Prior radiation therapy for prostate cancer
  • History of cardiac conditions
  • Prohibited study medications

Cheryl Ahlstrom, Patient Liaison
South Florida Medical Research
21150 Biscayne Blvd., Suite 300
Aventura, FL 33180
Phone: 305-931-8080
Fax: 305-931-8088
Email: cahlstrom@southfloridamedicalresearch.com

View Map

Research Center Information: South Florida Medical Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.